Skip to content
Arquer Diagnostics logo — Leading the way in non-invasive tests for diagnosing and mon...

Arquer Diagnostics

Leading the way in non-invasive tests for diagnosing and monitoring cancer.

Founded 2006 United Kingdom Sunderland, United Kingdom 3 employees Convertible Note Total: $8.48M Biotechnology, Health Care +1

General Information

Company Name Arquer Diagnostics
Founded Year 2006
Location United Kingdom Sunderland, United Kingdom
Employees 3
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Arquer Diagnostics. To contact Arquer Diagnostics, visit arquerdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arquer Diagnostics compare?

A PDF of Arquer Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arquer Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arquer Diagnostics

Arquer Diagnostics is a biotechnology startup that specializes in the healthcare industry. Founded in 2006, the company recently secured a £2.49M Convertible Note investment on 24 March 2022. The investment came from Northstar Ventures, a noteworthy investor in the startup space. With a focus on biotechnology and healthcare, Arquer Diagnostics is positioned to make impactful contributions to the medical field.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note £2.49M 1
Northstar Ventures
24 Mar 2022
Series B Undisclosed 1
Northstar Ventures
20 Mar 2019
Series B £2.10M 2
Longwall Ventures, Esperante Ventures
03 Oct 2017
Grant £70.00K 1
Innovate UK
01 Mar 2017
Venture Round £2.00M 4
Northstar Ventures, Longwall Ventures +2
16 Jan 2015
Seed Round £429.45K 2
Northstar Ventures, Esperante Ventures
14 Feb 2014
Seed Round £750.00K -
19 Jun 2013
Seed Round £638.88K 3
Northstar Ventures, Esperante Ventures +1
31 Aug 2012

Arquer Diagnostics Alternatives & Competitors

Arquer Diagnostics vs
Wren Laboratories
Wren Laboratories United States

Unleashing the Power of mRNA and AI for Cancer Diagnostics

25 employees
Biotechnology, Health Care
Arquer Diagnostics vs

Leading the way in patient-specific cancer genome analysis with groundbreaking technologies for non-...

Series C
0-1 employees
Analytics, Biotechnology

FAQ About Arquer Diagnostics

Leading the way in non-invasive tests for diagnosing and monitoring cancer.
Arquer Diagnostics was founded in 2006.
Arquer Diagnostics is headquartered in Sunderland, United Kingdom.
Arquer Diagnostics operates in Biotechnology, Health Care and Medical Devices.
Arquer Diagnostics has approximately 3 employees.
Arquer Diagnostics has completed 8 funding rounds, raising a total of $8.48M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Arquer Diagnostics include Wren Laboratories, Personal Genome Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arquer Diagnostics and Wren Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arquer Diagnostics, https://bouncewatch.com/company/arquer-diagnostics, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout